From October 1, 2022 to January 14, 2023, the company has repurchased 1,390,836 shares, representing 0.35% for INR 67.66 million. With this, the company has completed the repurchase of 6,474,276 shares, representing 1.59% for INR 321.14 million under the buyback announced on July 8, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
163.8 INR | +2.97% | -0.74% | +1.66% |
31/05 | Transcript : Marksans Pharma Limited, Q4 2024 Earnings Call, May 31, 2024 | |
30/05 | INDIA STOCKS-Indian shares fall for fifth session on weak global cues, election uncertainties | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.66% | 865M | |
+56.86% | 815B | |
+43.90% | 641B | |
-6.57% | 352B | |
+17.32% | 314B | |
+9.94% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+7.98% | 168B |
- Stock Market
- Equities
- MARKSANS Stock
- News Marksans Pharma Limited
- Tranche Update on Marksans Pharma Limited's Equity Buyback Plan announced on July 8, 2022.